Issue 42, 2017

Radionuclides in oncology clinical practice – review of the literature

Abstract

Radionuclide therapy is a type of targeted therapy that can be useful in the treatment of several malignant tumors. Compared with other forms of systemic therapy used in cancer – including chemotherapy – it has the advantage of sparing biological structures adjacent to the tumor cells. This treatment modality has registered significant advances since its first use for the treatment of tuberculous skin lesions in the 1900s. This paper reviews the characteristics and clinical applications of therapeutic radionuclides commonly used in the oncology clinical practice, and discusses future potential applications.

Graphical abstract: Radionuclides in oncology clinical practice – review of the literature

Article information

Article type
Perspective
Submitted
27 mai 2017
Accepted
11 set 2017
First published
11 set 2017

Dalton Trans., 2017,46, 14475-14487

Radionuclides in oncology clinical practice – review of the literature

H. Luna Pais, I. Alho, I. Vendrell, A. Mansinho and L. Costa, Dalton Trans., 2017, 46, 14475 DOI: 10.1039/C7DT01929G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements